LP
EHC icon

Longaeva Partners’s Encompass Health EHC Stock Holding History

Longaeva Partners’s Portfolio EHC Stock Details EHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.08M Buy
+70,000
New +$7.25M 0.15% 144

Other funds holding EHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Longaeva Partners's EHC Position: Q2 2026 in Review

Longaeva Partners opened a new position in Encompass Health (EHC) in Q2 2026: 70,000 shares worth $7.08M. The stake represents 0.15% of the portfolio and ranks #144 among its holdings.

597 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • Longaeva Partners held 70,000 shares of Encompass Health worth $7.08M as of Q2 2026.
  • Encompass Health was a new Longaeva Partners position in Q2 2026.
  • Encompass Health made up 0.15% of Longaeva Partners's portfolio in Q2 2026, its #144 holding.
  • 597 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on Longaeva Partners's 13F filing for Q2 2026, filed 14 Aug 2026.